+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893302
Description Jump to:
The global xerostomia therapeutics market size is expected to reach USD 2.70 billion by 2030, expanding at a CAGR of 3.8% from 2023 to 2030. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren’s syndrome, diabetes, hypertension, and Parkinson’s disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren’s syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the “5-Year Breakthrough Goal” with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Xerostomia Therapeutics Market Report Highlights

  • The global xerostomia therapeutics market size was estimated at USD 2.0 billion in 2022 and is expected to grow with CAGR of 3.8% from 2023 to 2030
  • The OTC segment dominated the market due to factors such as ease in availability, affordability, and higher efficiency
  • The dentifrices segment is expected to grow at the fastest CAGR over the forecast period.
  • North America held the largest share in 2022 owing to factors such as increasing prevalence of diseases resulting in dry mouth and growing initiatives for raising awareness about xerostomia
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing awareness of the disease and growing healthcare expenditure
  • Some of the key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia therapeutics market

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Xerostomia Therapeutics Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis
4.1. Xerostomia Therapeutics Market: Key Takeaways
4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Over-the-counter (OTC)
4.3.1. Over-the-counter (OTC) market estimates and forecast 2018 to 2030 (USD million)
4.4. Prescription
4.4.1. Prescription market estimates and forecast 2018 to 2030 (USD million)
Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis
5.1. Xerostomia Therapeutics Market: Key Takeaways
5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Salivary Stimulants
5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
5.4. Salivary Substitutes
5.4.1. Salivary substitutes market estimates and forecast 2018 to 2030 (USD Million)
5.5. Dentifrices
5.5.1. Dentifrices market estimates and forecast 2018 to 2030 (USD million)
Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. China
6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.5.2. Japan
6.5.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
6.5.3. India
6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Acacia Pharma
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Type benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Parnell Pharmaceuticals, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Type benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Pfizer, Inc.
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Type benchmarking
7.2.3.4. Strategic initiatives
7.2.4. GlaxoSmithKline plc
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Type benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Church & Dwight Co., Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Type benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Lupin
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Type benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Sun Pharmaceutical Industries, Ltd.
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Type benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Hikma Pharmaceuticals PLC
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Type benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Pendopharm
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Type benchmarking
7.2.9.4. Strategic initiatives
7.2.10. OraCoat
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Type benchmarking
7.2.10.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 3 North America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 North America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 7 Canada xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 8 Canada xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 9 Europe xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 10 Europe xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 Europe xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 12 Germany xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 13 Germany xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 14 UK xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 15 UK xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 16 France xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 17 France xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 18 Italy xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 19 Italy xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 20 Spain xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 21 Spain xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 22 Sweden xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 24 Norway xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 25 Norway xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 26 Denmark xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 28 APAC xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 29 APAC xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 APAC xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 31 Japan xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 32 Japan xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 33 China xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 34 China xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 35 India xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 36 India xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 37 Australia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 38 Australia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 39 Thailand xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 41 South Korea xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 43 Latin America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 48 Mexico xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 50 Argentina xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 56 South Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 59 UAE xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 60 UAE xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
Table 61 Kuwait xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Xerostomia therapeutics: market outlook
Fig. 9 Xerostomia therapeutics competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Xerostomia therapeutics market driver impact
Fig. 15 Xerostomia therapeutics market restraint impact
Fig. 16 Xerostomia therapeutics market strategic initiatives analysis
Fig. 17 Xerostomia therapeutics market: type movement analysis
Fig. 18 Xerostomia therapeutics market: type outlook and key takeaways
Fig. 19 Over-the-counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Xerostomia therapeutics market: product movement analysis
Fig. 22 Xerostomia therapeutics market: product outlook and key takeaways
Fig. 23 Salivary stimulants market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Salivary substitutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Dentifrices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Xerostomia therapeutics market: material movement analysis
Fig. 27 Global xerostomia therapeutics market: regional movement analysis
Fig. 28 Global xerostomia therapeutics market: regional outlook and key takeaways
Fig. 29 North America, by country
Fig. 30 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Europe. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Companies Mentioned

  • Acacia Pharma
  • Parnell Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Church & Dwight Co., Inc.
  • Lupin
  • Sun Pharmaceutical Industries, Ltd.
  • Hikma Pharmaceuticals PLC
  • Pendopharm
  • OraCoat

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.7 Billion
Compound Annual Growth Rate3.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Xerostomia Therapeutics Market by Offering, Drug Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Xerostomia Therapeutics Market by Offering, Drug Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Xerostomia Therapeutics Market Analysis & Forecast to 2024-2034 - Product Image

Xerostomia Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Xerostomia Therapeutics Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032 - Product Image

Xerostomia Therapeutics Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From
Global Xerostomia Therapeutics Market Report 2024 - Product Image

Global Xerostomia Therapeutics Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report - Product Image

Xerostomia (Dry Mouth) Therapeutics - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.